Published in Women's Health Weekly, July 29th, 2004
Physicians should consider these data as part of the individualized assessment of the appropriateness of postmenopausal hormone therapy. According to Wyeth Pharmaceuticals, a division of Wyeth (WYE), however, these data may not directly apply to newly menopausal women, a group not studied in WHIMS.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly